Burlet A, Tonon M C, Tankosic P, Coy D, Vaudry H
Neuroendocrinology. 1983 Jul;37(1):64-72. doi: 10.1159/000123517.
The localization of CRF-41 related peptide was studied in the brain and posterior pituitary of the homozygous rats for the inherited diabetes insipidus (Brattleboro strain, DI) and of the Long-Evans rats (LE) as control. It was compared to the distribution of vasopressin (AVP), oxytocin (OXY) and OXY-neurophysin (N I). In both strains, CRF-41 was identified in two morphologically distinct systems: one was a hypothalamoneurohypophysial system simultaneously containing CRF-41, OXY and N I; the other was a hypothalamoinfundibular system carrying CRF-41 only. CRF containing neurons were located in the periventricular area of the anterior hypothalamus, in the retrochiasmatic part of the supraoptic nuclei (SON) and, for some of them, in the antechiasmatic part of SON. CRF immunostainings were enhanced by colchicine treatment in LE rats and by DDAVP therapy in DI rats.
在遗传性尿崩症纯合子大鼠(布拉特洛维大鼠品系,DI)及作为对照的长-伊文斯大鼠(LE)的脑和垂体后叶中,研究了与CRF-41相关肽的定位。将其与血管加压素(AVP)、催产素(OXY)及催产素-神经垂体素(NI)的分布进行了比较。在两个品系中,CRF-41均在两种形态学上不同的系统中被鉴定出来:一个是同时含有CRF-41、OXY和NI的下丘脑-神经垂体系统;另一个是仅携带CRF-41的下丘脑-漏斗系统。含CRF的神经元位于下丘脑前部的室周区域、视上核(SON)的视交叉后部分,其中一些还位于SON的视交叉前部分。在LE大鼠中,秋水仙碱处理增强了CRF免疫染色;在DI大鼠中,去氨加压素治疗增强了CRF免疫染色。